In comparative medicine, veterinary researchers have applied the immunophenotypes adopted from human breast cancer (HBC) to CMT using protein biomarkers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). The gene discussed is ESR1; the disease is breast carcinoma.